Pfizer steps up race for weight-loss drug
Pfizer says it is dropping the development of the obesity and diabetes drug lotiglipron and focusing on another treatment, as Ozempic maker Novo Nordisk trials a pill version of its drug. Reuters
Visit us at https://www.inquirer.net/r
Facebook: https://facebook.com/inquirerdotnet/r
Twitter: https://twitter.com/inquirerdotnet
Fastest update at www.pinoynetwork.su. Keep checking back for fresh new videos uploaded everyday.
( Advertise in videos.) Ads are skippable with “Skip Ad” buttons appearing after 3-10 seconds...
Please REFRESH this page if the video are not yet complete or error. Thank you for patience. Enjoy watching. ^_^
